Allergo-Med Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Allergo-Med Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services

Secondary Activities: Printing | Pharmacies and Drug Stores | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Offices of Physicians

Full name: Allergo-Med Sp. z o.o.

Profile Updated: October 01, 2024

Allergo-Med Sp. z o.o. is based in Poland, with the head office in Gliwice. It operates in the Ambulatory Health Care Services sector. It was incorporated on December 20, 2001. It currently has a total number of 51 - 100 (2008) employees. In 2023, the company reported a net sales revenue increase of 31.49%. There was a total growth of 55.19% in Allergo-Med Sp. z o.o.’s total assets over the same period. The net profit margin of Allergo-Med Sp. z o.o. increased by 0.99% in 2023.

Headquarters
Ul. Kilinskiego 15
Gliwice; Slaskie; Postal Code: 44-100

Contact Details: Purchase the Allergo-Med Sp. z o.o. report to view the information.

Website: http://www.allergo-med.pl

Basic Information

Total Employees:

Purchase the Allergo-Med Sp. z o.o. report to view the information.

Outstanding Shares:

Purchase the Allergo-Med Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Allergo-Med Sp. z o.o. report to view the information.

Incorporation Date:

December 20, 2001

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

58%

Purchase this report to view the information.

24%

Company Performance

Financial values in the chart are available after Allergo-Med Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

31.49%▲

Total operating revenue

31.71%▲

Operating profit (EBIT)

34.8%▲

EBITDA

36.6%▲

Net Profit (Loss) for the Period

37.23%▲

Total assets

55.19%▲

Total equity

56.78%▲

Operating Profit Margin (ROS)

0.62%▲

Net Profit Margin

0.99%▲

Return on Equity (ROE)

-5.16%▼

Quick Ratio

0.61%▲

Similar companies

Related EMIS Industry Reports